NO20020676D0 - Oral administration containing probiotic microorganisms - Google Patents

Oral administration containing probiotic microorganisms

Info

Publication number
NO20020676D0
NO20020676D0 NO20020676A NO20020676A NO20020676D0 NO 20020676 D0 NO20020676 D0 NO 20020676D0 NO 20020676 A NO20020676 A NO 20020676A NO 20020676 A NO20020676 A NO 20020676A NO 20020676 D0 NO20020676 D0 NO 20020676D0
Authority
NO
Norway
Prior art keywords
oral administration
probiotic microorganisms
administration containing
containing probiotic
microorganisms
Prior art date
Application number
NO20020676A
Other languages
Norwegian (no)
Other versions
NO20020676L (en
Inventor
Joachim Bug
Iris Manneck
Martina Schmid
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20020676D0 publication Critical patent/NO20020676D0/en
Publication of NO20020676L publication Critical patent/NO20020676L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20020676A 1999-08-12 2002-02-11 Oral administration containing probiotic microorganisms NO20020676L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19937361A DE19937361A1 (en) 1999-08-12 1999-08-12 Oral dosage form
PCT/EP2000/006580 WO2001012164A1 (en) 1999-08-12 2000-07-12 Oral form of administration containing probiotic micro-organisms

Publications (2)

Publication Number Publication Date
NO20020676D0 true NO20020676D0 (en) 2002-02-11
NO20020676L NO20020676L (en) 2002-02-11

Family

ID=7917589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020676A NO20020676L (en) 1999-08-12 2002-02-11 Oral administration containing probiotic microorganisms

Country Status (20)

Country Link
EP (1) EP1207859B1 (en)
JP (1) JP2003506481A (en)
KR (1) KR20020031383A (en)
CN (1) CN1364076A (en)
AR (1) AR025020A1 (en)
AT (1) ATE276746T1 (en)
AU (1) AU770792B2 (en)
BR (1) BR0013110A (en)
CA (1) CA2377415A1 (en)
CZ (1) CZ2002354A3 (en)
DE (2) DE19937361A1 (en)
HK (1) HK1048065A1 (en)
HU (1) HUP0203029A3 (en)
MX (1) MXPA02000630A (en)
NO (1) NO20020676L (en)
PL (1) PL353878A1 (en)
RU (1) RU2002105484A (en)
SK (1) SK1632002A3 (en)
WO (1) WO2001012164A1 (en)
ZA (1) ZA200110534B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
DE10206995B4 (en) * 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Micronutrient combination product with pro- and prebiotics
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
DE102004026706A1 (en) * 2004-05-28 2005-12-15 Merck Patent Gmbh Oral dosage form containing probiotic bacteria
US20100233312A9 (en) * 2005-04-11 2010-09-16 The Procter & Gamble Company Compositions comprising probiotic and sweetener components
EP1885207B1 (en) 2005-05-18 2011-07-06 DSM IP Assets B.V. Compositions for enteral application of microorganisms
JP4938006B2 (en) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー Feline probiotic bifidobacteria
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
DE202007013316U1 (en) 2007-09-21 2009-02-12 Voss Automotive Gmbh Connecting device for media lines
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2808610C (en) 2010-08-10 2018-09-25 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
JP2014189547A (en) * 2013-03-28 2014-10-06 Lintec Corp Swallowed object cover
WO2015190456A1 (en) * 2014-06-10 2015-12-17 ライオン株式会社 Tablet containing sake yeast
MX2018001849A (en) * 2015-08-31 2018-05-16 Nestec Sa Methods and compositions using bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances.
CN107115311A (en) * 2017-05-04 2017-09-01 江苏大学 A kind of Bifidobacterium enteric coatel tablets and preparation method thereof
EP4081195A1 (en) * 2019-12-27 2022-11-02 Evelo Biosciences, Inc. Solid dosage forms containing bacteria and microbial extracellular vesicles
CN115551486A (en) * 2020-04-17 2022-12-30 伊夫罗生物科学公司 Solid dosage forms with improved disintegration profile
US11426353B2 (en) * 2020-06-24 2022-08-30 13400719 Canada Inc. Composite coating for an active agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62201823A (en) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd Material containing beneficial enterobacterium and production thereof
IT1197316B (en) * 1986-10-01 1988-11-30 Proter Spa GALENIC FORMULATION FOR ORAL USE OF REINA DERIVATIVES SLOWLY RELEASED FOR THERAPEUTIC USE
JPH0441434A (en) * 1990-06-07 1992-02-12 Asahi Breweries Ltd Lactobacillus tablet provided with enteric coating
JP3083169B2 (en) * 1991-02-27 2000-09-04 日清製粉株式会社 Bifidobacterium preparation and its production method
JP3187502B2 (en) * 1992-01-09 2001-07-11 カネボウ株式会社 Enteric granules
JP2859217B2 (en) * 1995-08-10 1999-02-17 日清製粉株式会社 Method for producing granules containing useful intestinal bacteria
KR100387245B1 (en) * 1997-10-17 2003-08-19 일양약품주식회사 Enteric coated microgranules for stabilizing lactic acid bacteria
JPH11139978A (en) * 1997-11-06 1999-05-25 Asahi Beer Yakuhin Kk Enteric live bacterium preparation

Also Published As

Publication number Publication date
BR0013110A (en) 2002-05-07
HUP0203029A3 (en) 2004-10-28
HK1048065A1 (en) 2003-03-21
WO2001012164A1 (en) 2001-02-22
DE50007927D1 (en) 2004-10-28
JP2003506481A (en) 2003-02-18
SK1632002A3 (en) 2002-06-04
HUP0203029A2 (en) 2002-12-28
EP1207859B1 (en) 2004-09-22
CA2377415A1 (en) 2001-02-22
AU770792B2 (en) 2004-03-04
ZA200110534B (en) 2003-07-30
CZ2002354A3 (en) 2002-05-15
ATE276746T1 (en) 2004-10-15
NO20020676L (en) 2002-02-11
RU2002105484A (en) 2003-11-20
EP1207859A1 (en) 2002-05-29
AR025020A1 (en) 2002-11-06
CN1364076A (en) 2002-08-14
AU6158100A (en) 2001-03-13
MXPA02000630A (en) 2002-08-30
KR20020031383A (en) 2002-05-01
DE19937361A1 (en) 2001-02-22
PL353878A1 (en) 2003-12-01

Similar Documents

Publication Publication Date Title
NO20020676D0 (en) Oral administration containing probiotic microorganisms
NO20020208L (en) Liquid compositions for oral administration
TR200003788A3 (en) Yavas release oral dosage composition.
ZA200202480B (en) Oral dosage forms.
HUP0203204A3 (en) Oral dosage forms
AU1998200A (en) Multiparticulate oral dosage forms
FI991485A (en) New pharmaceutical composition
IS6263A (en) Pharmaceutical formulations containing tripeptide
TR200003787A3 (en) Stable slow-release oral dosage composition.
MXPA03004941A (en) Drug formulation having improved oral tolerability.
AU4024100A (en) Anti-caries oral care compositions
ATE264680T1 (en) BETA-CARBOLINE MEDICINAL PRODUCTS
DE60045402D1 (en) Silylalkylplatinum (IV) compounds and their preparation
ITMI982222A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS CONTAINING BUPRENERPHINE
IL154850A0 (en) Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same
DE69807768D1 (en) Oral administration formulations containing rapamycin
PT1227817E (en) AQUOSA PHARMACEUTICAL COMPOSITION CYCLOSONIDE CONTAINING
ID30397A (en) PRUKALOPRIDA ORAL SOLUTION
HUP0201667A3 (en) Oral form of administration
DK1216032T3 (en) Controlled-release oral formulations
HUP0201914A3 (en) Oral care composition
PL1663101T3 (en) Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
ITMO990002A0 (en) ARTICULATOR FOR DENTAL TECHNOLOGY.
ZA200108206B (en) Oral pharmaceutical ibuprofen suspension.
HK1047232A1 (en) Oral dosage forms

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application